Crosstalk of EGF-directed MAPK signalling pathways and its potential role on EGF-induced cell proliferation and COX-2 expression in human mesenchymal stem cells

Cell Biochemistry and Function

Volumn 29, Issue 1, 2011, Pages 64-70

  Sabri, Abdullah ^a   Ziaee, Abed Ali ^a   Ostad, Seyed Nasser ^b   Alimoghadam, Kamran ^c   Ghahremani, Mohammad Hossein ^b  

^a UNIVERSITY OF TEHRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

AKT; COX 2; Epidermal growth factor; ERK; JNK; Mesenchymal stem cells; P38

Indexed keywords

BROMINE DERIVATIVE; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; METHYLTHIAZOLYL TETRAZOLIUM BROMIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CELL THERAPY; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MESENCHYMAL STEM CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELL PROLIFERATION; CELLS, CULTURED; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STEM CELLS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR CROSS-TALK;

EID: 78851471999     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1720     Document Type: Article

References (31)

1. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
2. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-1822. 2004-04-1559[pii]10.1182/blood-2004-04-1559.
3. Liu B, Chen H, Johns TG, Neufeld AH. Epidermal growth factor receptor activation: an upstream signal for transition of quiescent astrocytes into reactive astrocytes after neural injury. J Neurosci 2006; 26: 7532-7540. 26/28/7532[pii]1523/JNEUROSCI.1004-06.2006.
4. Carpenter G. Receptor tyrosine kinase substrates: src homology domains and signal transduction. FASEB J 1992; 6: 3283-3289.
5. Tamama K, Fan VH, Griffith LG, Blair HC, Wells A. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells 2006; 24: 686-695. 2005-0176[pii]1634/stemcells.2005-0176.
6. Tamama K, Kawasaki H, Wells A. Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC. J Biomed Biotechnol 2010; 2010: 795385. 10.1155/2010/795385.
7. Wells A. EGF receptor. Int J Biochem Cell Biol 1999; 31: 637-643.DOI: 10.1016/s1357-2725(99)00015-1.
8. Wells A, Ware MF, Allen FD, Lauffenburger DA. Shaping up for shipping out: PLCγ signaling of morphology changes in EGF-stimulated fibroblast migration. Cell Motil Cytoskel 1999; 44: 227-233. 10.1002/(sici)1097-0169(199912)44:4<227::aid-cm1>3.0.co;2-b
9. Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 1999; 79: 143-180.
10. Garrington TP, Johnson GL. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 1999; 11: 211-218.
11. Wilkinson MG, Millar JB. Control of the eukaryotic cell cycle by MAP kinase signaling pathways. FASEB J 2000; 14: 2147-2157.
12. Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 2009; 9: 537-549. nrc2694[pii]1038/nrc2694.
13. Husvik C, Bryne M, Halstensen TS. Epidermal growth factor-induced cyclooxygenase-2 expression in oral squamous cell carcinoma cell lines is mediated through extracellular signal-regulated kinase 1/2 and p38 but is Src and nuclear factor-kappa B independent. Eur J Oral Sci 2009; 117: 528-535. EOS669[pii]1111/j.1600-0722.2009.00669.x
14. Kleiveland CR, Kassem M, Lea T. Human mesenchymal stem cell proliferation is regulated by PGE2 through differential activation of cAMP-dependent protein kinase isoforms. Exp Cell Res 2008; 314: 1831-1838. S0014-4827(08)00079-7[pii]1016/j.yexcr.2008.02.004.
15. Matsuura H, Sakaue M, Subbaramaiah K, et al. Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases. J Biol Chem 1999; 274: 29138-29148.
16. Xu K, Shu HK. EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas. Cancer Res 2007; 67: 6121-6129. 67/13/6121 [pii] 1158/0008-5472.CAN-07-0141.
17. Zhang X, Neufeld AH. Signal transduction pathways for epidermal growth factor stimulated cyclooxygenase-2 induction in astrocytes. Exp Eye Res 2007; 85: 280-288. S0014-4835(07)00135-2 [pii] 10.1016/j.exer.2007.05.002.
18. Smith WL, Marnett LJ, DeWitt DL. Prostaglandin and thromboxane biosynthesis. Pharmacol Ther 1991; 49: 153-179. 0163-7258(91) 90054-P [pii]
19. Muschler GF, Midura RJ. Connective tissue progenitors: practical concepts for clinical applications. Clin Orthop Relat Res 2002; 66-80.
20. Krampera M, Pasini A, Rigo A, et al. HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation. Blood 2005; 106: 59-66. 2004-09-3645 [pii] 1182/blood-2004-09-3645.
21. Choi SC, Kim SJ, Choi JH, Park CY, Shim WJ, Lim DS. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways. Stem Cells Dev 2008; 17: 725-736. 10.1089/scd.2007.0230.
22. Cheng M, Sexl V, Sherr CJ, Roussel MF. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc Natl Acad Sci USA 1998; 95: 1091-1096.
23. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002; 296: 1655-1657. 10.1126/science.296.5573.1655.
24. Maddika S, Ande SR, Wiechec E, Hansen LL, Wesselborg S, Los M. Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis. J Cell Sci 2008; 121: 979-988. 10.1242/jcs.009530.
25. Higuchi C, Myoui A, Hashimoto N, et al. Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix. J Bone Miner Res 2002; 17: 1785-1794. 10.1359/jbmr.2002.17.10.1785.
26. Kita K, Kimura T, Nakamura N, Yoshikawa H, Nakano T. PI3K/Akt signaling as a key regulatory pathway for chondrocyte terminal differentiation. Genes Cells 2008; 13: 839-850. GTC1209 [pii] 1111/j.1365-2443.2008.01209.x
27. Hu X, Janssen WE, Moscinski LC, et al. An IkappaBalpha inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanism. Cancer Res 2001; 61: 6290-6296.
28. Ahn HJ, Lee WJ, Kwack K, Kwon YD. FGF2 stimulates the proliferation of human mesenchymal stem cells through the transient activation of JNK signaling. FEBS Lett 2009; 583: 2922-2926. S0014-5793 (09)00609-7 [pii] 10.1016/j.febslet.2009.07.056.
29. Koistinaho M, Koistinaho J. Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia 2002; 40: 175-183. 10.1002/glia.10151.
30. Sun H, Xu B, Inoue H, Chen QM. P38 MAPK mediates COX-2 gene expression by corticosterone in cardiomyocytes. Cell Signal 2008; 20: 1952-1959. S0898-6568(08)00198-8 [pii] 1016/j.cellsig.2008.07.003.
31. 2 and EGF receptor through MAPKs in mouse embryonic stem cell proliferation. Cell Mol Life Sci 2009; 66: 1603-1616. 10.1007/s00018-009-9076-8.